Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03790358 · ClinicalTrials.gov registry record · Phase 1
Mood Effects of Serotonin Agonists
A Phase 1 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT03790358 is a Phase 1 study that has completed, run by University of Chicago. The registered enrollment target is 80 participants.
The verdict
NCT03790358, a Phase 1 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of very low doses of serotonergic agonists on depressed mood in human volunteers.
Interventions
- DRUG Lysergic Acid Diethylamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2023-01-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03790358
The ClinicalTrials.gov registry entry for NCT03790358 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lysergic Acid Diethylamide is the first listed.
NCT03790358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03790358 about?
NCT03790358 is a clinical study titled "Mood Effects of Serotonin Agonists". The purpose of this study is to determine the effects of very low doses of serotonergic agonists on depressed mood in human volunteers.
What is the current status of trial NCT03790358?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2018-05-01. Estimated completion is 2023-01-27.
What interventions are being tested in trial NCT03790358?
The interventions under investigation include: Lysergic Acid Diethylamide (DRUG).
Who is sponsoring clinical trial NCT03790358?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.